JENKINS GEORGE M 4

What Happened
George M. Jenkins, a director of Palvella Therapeutics, purchased 4,000 shares of Palvella common stock on February 27, 2026 at $125.00 per share, for a total transaction value of $500,000. This was a purchase (code P) rather than a sale.

Key Details

• Transaction date: 2026-02-27; Price: $125.00 per share; Shares acquired: 4,000; Total value: $500,000.
• Transaction type: Purchase (code P) — shares acquired in the company offering.
• Filing date: 2026-03-02 (filed timely for a Feb 27 transaction).
• Shares owned after the transaction: Not specified in the provided filing excerpt.
• Footnotes from the filing: F1 — these shares were purchased in the underwritten offering of Palvella at the offering price, which closed on Feb 27, 2026. F2 — references "Eagles Mere Air Museum Foundation" (listed in the filing footnotes; no additional detail provided here).

Context
This purchase was part of an underwritten offering that closed on Feb 27, 2026, meaning the director participated at the offering price rather than buying on the open market. Purchases by insiders can be informative to investors, but they do not by themselves explain the insider’s motivations.